A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

NCT02685774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg
DRUG: CKD-395 0.25/500mg

Sponsor

Chong Kun Dang Pharmaceutical